SCHEMBL18612719

SCHEMBL18612719

CC(C)(C)c1cc(-n2ccc3ccccc32)c(O)c(C(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HSP90AA1 P07900 4/20 0.39
▸ TRAP1 Q12931 2/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ HSP90B1 P14625 1/20 0.38
▸ KCNH2 Q12809 1/20 0.36
▸ BIRC5 O15392 1/20 0.36
▸ ALOX5 P09917 2/20 0.35
▸ PTGS2 P35354 2/20 0.35
▸ F2R P25116 1/20 0.35
▸ PRKD3 O94806 1/20 0.35
▸ PRKCG P05129 1/20 0.35
▸ PRKCB P05771 1/20 0.35
▸ PRKCA P17252 1/20 0.35
▸ PRKACA P17612 1/20 0.35
▸ PRKACG P22612 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14702271 0.82 HSP90AA1 (0.36) CYP1A2CYP3A4CYP2C9CYP2C19HSP90AA1
SCHEMBL14702069 0.80 HSP90AA1 (0.35) CYP1A2CYP3A4CYP2C9CYP2C19HSP90AA1
SCHEMBL9002281 0.78 TSHR (0.46) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL18593382 0.77 TSHR (0.44) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL28842775 0.74 KCNH2 (0.43) HSP90AA1TRAP1HSP90AB1HSP90B1KCNH2
SCHEMBL14703028 0.73 CYP2D6 (0.36) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL14705636 0.73 CYP2D6 (0.36) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16077903 0.73 CYP2D6 (0.36) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL14702083 0.73 CYP2D6 (0.36) CYP1A2CYP2C9TSHRCYP2C19HSP90AA1
SCHEMBL18593380 0.72 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND AOX1, NOX4, NOXO1 CYP1A2 139/4885CYP3A4 137/4885CYP2C9 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback